{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:11:21Z","timestamp":1778274681639,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022850","name":"The Little Princess Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002089","name":"Fight for Sight","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000774","name":"Newcastle University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["EP\/Y031016\/1"],"award-info":[{"award-number":["EP\/Y031016\/1"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/X012360\/1"],"award-info":[{"award-number":["MR\/X012360\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omton.2026.201160","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:51:19Z","timestamp":1771519879000},"page":"201160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-4170","authenticated-orcid":false,"given":"Joe","family":"Kelk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Rozanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Sotiriadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Astley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafiqul","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne","family":"Unsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbie","family":"Gangar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archie","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Queen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Coxhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyle","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Parulekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Veal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1327-8573","authenticated-orcid":false,"given":"Majlinda","family":"Lako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201160_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.molmed.2016.07.010","article-title":"Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine","volume":"22","author":"Dyer","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omton.2026.201160_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/apjon.apjon_18_17","article-title":"Neonatal retinoblastoma","volume":"4","author":"Kivel\u00e4","year":"2017","journal-title":"Asia Pac. J. Oncol. Nurs."},{"key":"10.1016\/j.omton.2026.201160_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08880010591002233","article-title":"CANCER IN INFANTS: A Review of 82 Cases","volume":"22","author":"Yang","year":"2005","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201160_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3109\/08880018.2013.813099","article-title":"Cancer incidence and survival among infants in Israel, 1998-2007","volume":"30","author":"Rabinowicz","year":"2013","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201160_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjo.2008.139626","article-title":"Retinoblastoma: Treatment and survival in Great Britain 1963 to 2002","volume":"93","author":"MacCarthy","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/IJO.IJO_2414_23","article-title":"Retinoblastoma \u2013 A comprehensive review, update and recent advances","volume":"72","author":"Nag","year":"2024","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib7","article-title":"Different Types of Clinical Presentations and Stages of Retinoblastoma Among Children","volume":"12","author":"Moeez Uddin","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.omton.2026.201160_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1542\/peds.2008-0518","article-title":"Retinoblastoma: One world, one vision","volume":"122","author":"Rodriguez-Galindo","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.omton.2026.201160_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00417-019-04589-4","article-title":"Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma","volume":"258","author":"Fabian","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4274\/tjo.06888","article-title":"Chemotherapy in Retinoblastoma: Current Approaches","volume":"45","author":"Yan\u0131k","year":"2015","journal-title":"Turk. J. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/ijo.IJO_883_16","article-title":"Recent advances and challenges in the management of retinoblastoma","volume":"65","author":"Chawla","year":"2017","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28348","article-title":"Cystoid macular edema following intravitreal chemotherapy treatment for retinoblastoma","volume":"67","author":"Panthagani","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.omton.2026.201160_bib13","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.ophtha.2018.05.013","article-title":"Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras","volume":"125","author":"Dalvin","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omton.2026.201160_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40942-018-0119-x","article-title":"Choroidal infarction following ophthalmic artery chemotherapy","volume":"4","author":"Bohm","year":"2018","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.omton.2026.201160_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12886-020-01512-y","article-title":"Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: A case report","volume":"20","author":"Stathopoulos","year":"2020","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib16","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and Cancer: Statistical Study of Retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2026.201160_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jmedgenet-2014-102264","article-title":"RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients","volume":"51","author":"Dommering","year":"2014","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.omton.2026.201160_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep25264","article-title":"Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes","volume":"6","author":"Kooi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2026.201160_bib19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/gcc.20383","article-title":"Profiling genomic copy number changes in retinoblastoma beyond loss of RB1","volume":"46","author":"Bowles","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.omton.2026.201160_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153323","article-title":"A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression","volume":"11","author":"Kooi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2026.201160_bib21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ophtha.2019.12.005","article-title":"Next-generation sequencing of retinoblastoma identifies pathogenic alterations beyond RB1 inactivation that correlate with aggressive histopathologic features","volume":"127","author":"Afshar","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omton.2026.201160_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ceo.12132","article-title":"The genomic landscape of retinoblastoma: a review","volume":"42","author":"Th\u00e9riault","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib23","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.4103\/IJO.IJO_3172_22","article-title":"Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies","volume":"71","author":"Rathore","year":"2023","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.omton.2026.201160_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000923","article-title":"Cdh11 Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell Death","volume":"6","author":"Marchong","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omton.2026.201160_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1158\/1541-7786.495.2.9","article-title":"Minimal 16q Genomic Loss Implicates Cadherin-11 in Retinoblastoma","volume":"2","author":"Marchong","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2026.201160_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.6.18","article-title":"Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing\u2014Opening Pathways to New Therapeutic Strategies?","volume":"62","author":"Collin","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omton.2026.201160_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/stcltm\/szac008","article-title":"pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation","volume":"11","author":"Rozanska","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omton.2026.201160_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s10637-020-01030-0","article-title":"A decision process for drug discovery in retinoblastoma","volume":"39","author":"Cancela","year":"2021","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.omton.2026.201160_bib29","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/stem.2883","article-title":"Human-Induced Pluripotent Stem Cells Generate Light Responsive Retinal Organoids with Variable and Nutrient-Dependent Efficiency","volume":"36","author":"Hallam","year":"2018","journal-title":"Stem Cell."},{"key":"10.1016\/j.omton.2026.201160_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13046-023-02608-1","article-title":"Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids","volume":"42","author":"Srimongkol","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201160_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1113\/jphysiol.1990.sp018067","article-title":"Active ion transport pathways in the bovine retinal pigment epithelium","volume":"424","author":"Miller","year":"1990","journal-title":"J. Physiol."},{"key":"10.1016\/j.omton.2026.201160_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3390\/pharmaceutics12060554","article-title":"Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs","volume":"12","author":"Hellinen","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.omton.2026.201160_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41392-025-02176-0","article-title":"The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy","volume":"10","author":"Vogler","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omton.2026.201160_bib34","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.leu.2404719","article-title":"ABT-737, an inhibitor of Bcl-2 family proteins, is a potent inducer of apoptosis in multiple myeloma cells","volume":"21","author":"Kline","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2026.201160_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bcp.2009.09.004","article-title":"ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin\u2013DNA adducts","volume":"79","author":"Ugarenko","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omton.2026.201160_bib36","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.cdd.4402178","article-title":"Crystal structure of ABT-737 complexed with Bcl-xL: Implications for selectivity of antagonists of the Bcl-2 family [1]","volume":"14","author":"Lee","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2026.201160_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106604","article-title":"High Bax\/Bcl-2 ratio is associated with good prognosis and better survival in patients with B cell chronic lymphocytic leukemia","volume":"107","author":"Helaly","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.omton.2026.201160_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13816810.2011.615077","article-title":"The Bcl-2\/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells","volume":"34","author":"Allaman-Pillet","year":"2013","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.omton.2026.201160_bib39","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1038\/s41388-020-1372-7","article-title":"Functional genomics identifies new synergistic therapies for retinoblastoma","volume":"39","author":"Aubry","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201160_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1471-2407-11-362","article-title":"The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma","volume":"11","author":"Lieber","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2026.201160_bib41","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/polym12081798","article-title":"Heat Shock Protein 90 (Hsp90)-Inhibitor-Luminespib-Loaded-Protein-Based Nanoformulation for Cancer Therapy","volume":"12","author":"K Rochani","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.omton.2026.201160_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Schopf","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omton.2026.201160_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/or.2022.8443","article-title":"HSP90 inhibitors and cancer: Prospects for use in targeted therapies","volume":"49","author":"Li","year":"2023","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2026.201160_bib44","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/ijc.31963","article-title":"Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma","volume":"144","author":"Augello","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2026.201160_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s42003-023-05732-y","article-title":"Single-cell transcriptomics enable the characterization of local extension in retinoblastoma","volume":"7","author":"Liu","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omton.2026.201160_bib46","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/s41467-021-25792-0","article-title":"A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201160_bib47","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/onc.2011.41","article-title":"Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice","volume":"30","author":"Buache","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2026.201160_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109827","article-title":"Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers","volume":"124","author":"Yi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2026.201160_bib49","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/17460441.2017.1356286","article-title":"Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma","volume":"12","author":"Karpel-Massler","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.omton.2026.201160_bib50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nor129","article-title":"RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines","volume":"13","author":"Levesley","year":"2011","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omton.2026.201160_bib51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsbiomaterials.8b00877","article-title":"Chemotherapeutic Drug Delivery and Quantitative Analysis of Proliferation, Apoptosis, and Migration in a Tissue-Engineered 3D Microvessel Model of the Tumor Microenvironment","volume":"5","author":"Wong","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.omton.2026.201160_bib52","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3390\/bioengineering8110186","article-title":"Recapitulating the Angiogenic Switch in a Hydrogel-Based 3D In Vitro Tumor-Stroma Model","volume":"8","author":"Kuehlbach","year":"2021","journal-title":"Bioengineering"},{"key":"10.1016\/j.omton.2026.201160_bib53","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1039\/D4LC00771A","article-title":"Retinal organoid chip: engineering a physiomimetic oxygen gradient for optimizing long term culture of human retinal organoids","volume":"25","author":"Drabbe","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.omton.2026.201160_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000370156","article-title":"Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing","volume":"1","author":"Cassoux","year":"2015","journal-title":"Ocul. Oncol. Pathol."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:24:43Z","timestamp":1778271883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2950329926000366"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201160","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal organoid screening reveals ABT-737 and luminespib as potential agents against a cone- precursor-derived subtype of retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201160"}}